Retraction: Building on a Strong Foundation to Address a New Era to Help Protect Against Pneumococcal Disease - European Medical Journal

Retraction: Building on a Strong Foundation to Address a New Era to Help Protect Against Pneumococcal Disease

Chairperson:
Antoni Torres1
Speakers:
Mário Ramirez,2,3 Charles Feldman,4 Wendy Watson5
Disclosure:

Torres has received honoraria for speaking engagements or advisory roles for Atriva Pharmaceuticals, Janssen, MSD, Menarini, and Pfizer. Ramirez has received fees for Pfizer speaker bureaus, GlaxoSmithKline expert panels, and Merck Sharp & Dohme speaker bureaus and expert panels. Feldman has received honoraria for speaking engagements or advisory roles for MSD and Pfizer. Watson is a Pfizer employee and holds stock/stock options. The studies in this presentation were funded by Pfizer.

Acknowledgements:

Writing assistance was provided by International Meetings & Science (IMsci), Stamford, Connecticut, USA.

Support:

The symposium and publication of this article were funded by Pfizer, Inc. The views and opinions expressed are exclusively those of the speakers.

Citation:
EMJ Microbiol Infect Dis. ;3[Suppl 1] https://doi.org/10.33590/emjmicrobiolinfectdis/IWYH8343.

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.

The sponsor of the below article (Pfizer, Inc) requested its retraction in accordance with their internal compliance requirements following an update to the Summary of Product Characteristics and prescribing information (PI). The article is no longer approved for use in its current format.

Please rate the quality of this content

As you found this content interesting...

Follow us on social media!

We are sorry that this content was not interesting for you!

Let us improve this content!

Tell us how we can improve this content?

Keep your finger on the pulse

Join Now

Elevating the Quality of Healthcare Globally

>